Technology versus tradition: a non-inferiority trial comparing video to face-to-face consultations with a physiotherapist for people with knee osteoarthritis. Protocol for the PEAK randomised controlled trial
BMC Musculoskeletal Disorders volume 21, Article number: 522 (2020)
Knee osteoarthritis (OA) is a global problem that causes significant pain and physical dysfunction, substantially impacting on quality of life and imposing enormous cost to the healthcare system. Exercise is pivotal to OA management, yet uptake by people with knee OA is inadequate. Limited access to appropriately skilled health professionals, such as physiotherapists, for prescription of an exercise program and support with exercise is a major barrier to optimal care. Internet-enabled video consultations permit widespread reach. However, services offering video consultations with physiotherapists for musculoskeletal conditions are scant in Australia where there is typically no Government or private health insurer funding for such services. The paucity of robust evidence demonstrating video consultations with physiotherapists are clinically effective, safe and cost-effective for knee OA is hampering implementation of, and willingness of healthcare policymakers to pay for, these services.
This is an assessor- and participant-blinded, two-arm, pragmatic, comparative effectiveness non-inferiority randomised controlled trial (RCT) conducted in Australia. We are recruiting 394 people from the community with chronic knee pain consistent with a clinical diagnosis of knee OA. Participants are randomly allocated to receive physiotherapy care via i) video-conferencing or; ii) face-to-face consultations. Participants are provided five consultations (30–45 min each) with a physiotherapist over 3 months for prescription of a home-based strengthening exercise program (to be conducted independently at home) and physical activity plan, as well as OA education. Participants in both groups are provided with educational booklets and simple exercise equipment via post. The co-primary outcomes are change in self-reported i) knee pain on walking; and ii) physical function, with a primary end-point of 3 months and a secondary end-point of 9 months. Secondary outcomes include changes in other clinical outcomes (health-related quality of life; therapeutic relationship; global ratings of change; satisfaction with care; self-efficacy; physical activity levels), time and financial costs of attending consultations, healthcare usage and convenience. Non-inferiority will be assessed using the per-protocol dataset.
Findings will determine if video consultations with physiotherapists are non-inferior to traditional face-to-face consultations for management of people with knee OA.
Australian New Zealand Clinical Trials Registry, ACTRN12619001240134. http://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377672&isReview=true
Arthritis and musculoskeletal conditions are an Australian National Health Priority Area, and more prevalent in Australia than any other, including cancer, diabetes and obesity . Osteoarthritis, particularly of the knee, is a leading cause of pain and disability in Australia, and the 12th highest contributor to global disability . Around 2.1 million Australians (1 in 11 people) have OA, with a 58% increase expected by 2032 due to population ageing and rising obesity rates . This reflects international data showing that OA accounted for 303.1 million prevalent cases across the globe in 2017 , with a 9.3% increase in age-standardised point prevalence since 2010. Knee OA can be extremely debilitating. Pain is a major symptom and it may become persistent and more limiting over time. Physical function can become increasingly impaired and may impact substantially on quality of life and ability to participate in social, leisure and occupational activities. Health expenditure on OA in Australia in 2012 was $3.75 billion, with most costs related to conservative and surgical treatments, lost productivity and loss of quality of life. With the aging and increasing obesity of the world’s population, a large increase in demand for health services for knee OA is expected in the future.
There is no cure for OA. Treatments to reduce symptoms and delay or prevent joint replacement are critical. Clinical guidelines for management of knee OA emphasise non-drug non-surgical strategies [4,5,6,7] that focus on self-help and patient-driven options rather than clinician-delivered passive therapies. In particular, advice and information for self-management, exercise and weight control (if required) are core management, with drugs, injections and manual therapy considered adjunctive to core treatments [4,5,6,7]. Exercise is advised for all people with knee OA irrespective of age, OA severity, pain, function and comorbidities . The benefits of exercise for knee OA on pain, physical function and quality of life are well-established [8, 9]. Given that muscle weakness is widespread in knee OA , muscle strengthening is an important component of exercise programs for people with the condition.
Knee OA is mostly managed in primary care settings, with physiotherapists frequently involved in provision of care. Physiotherapy is traditionally provided during face-to-face consultations in the clinic. However, for many people, access to physiotherapy is hampered by geographical isolation and/or limited physiotherapy services. This is particularly a problem in regional and remote areas where services are often limited or non-existent. Face-to-face consultations also pose an infection risk for both the physiotherapist and the patient. This has been highlighted by the COVID-19 pandemic where many physiotherapy practices across the globe have restricted or ceased face-to-face consultations and instead shifted towards telehealth, in order to safeguard the health of both patients and staff.
We conducted the first RCT evaluating efficacy of video consultations with a physiotherapist for exercise management of knee OA . We recruited 148 older people around Australia and compared video consultations (delivered by 8 different physiotherapists) combined with a self-directed online pain coping skills program, versus online education. Findings showed that the intervention significantly improved knee pain and physical function by clinically meaningful amounts at 3 months, and that benefits were sustained at 9 months. Furthermore, nested qualitative research showed that video consultations were acceptable to both patients and physiotherapists . Patient convenience, flexibility, empowerment to self-manage and positive therapeutic relationships were emphasised by both patients and physiotherapists. Patients were very satisfied with the care they received and believed it was effective for them personally. These findings reflect survey data in people with knee OA  and in patients attending hospital-based physiotherapy screening clinics , as well as RCT findings in patients following joint replacement . Collectively, research indicates most patients are willing to engage in video consultations for chronic musculoskeletal conditions. However, there is no research comparing the effectiveness of video-conferencing with physiotherapists to face-to-face consultations for people with knee OA.
The primary aim of this RCT is to determine if video-conferencing consultations are non-inferior to face-to-face consultations with a physiotherapist for improving knee pain on walking and/or physical function at 3 months (primary time-point) and 9 months (secondary time-point), in people with knee OA. We hypothesise that video consultations are not inferior for improving knee pain on walking and/or physical function compared to face-to-face care in people with knee OA. Secondary aims are to compare the clinical effectiveness (health-related quality of life, therapeutic relationship, global ratings of change, satisfaction with care, self-efficacy, physical activity levels), cost-effectiveness (participant-level travel time and travel-related costs, health care usage) and convenience of video-conferencing consultations to face-to-face consultations, as well as explore potential moderators of treatment effect.
A multi-site, two-arm, parallel, pragmatic, comparative effectiveness non-inferiority RCT is being conducted, with a health economic analysis. This protocol has been developed according to the SPIRIT statement . The RCT was prospectively registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12619001240134). Findings of the trial will be reported according to CONSORT guidelines for reporting of non-inferiority trials  and non-pharmacological interventions , and the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trial Network governance and publication policies (https://anzmusc.org).
A total of 394 people with chronic knee pain, consistent with a clinical diagnosis of knee OA, will be recruited. Participants are recruited from the community (in geographical locations surrounding our trial physiotherapists) in Victoria, Queensland, and New South Wales via community advertisements, print/radio/social media, clinicians and our volunteer database. Volunteers are initially screened by an online form, then over the phone by the Trial Coordinator. Volunteers uncomfortable with online screening can instead call a telephone number and proceed directly to phone screening. Participants are eligible for the study if they meet the following inclusion criteria:
meet National Institute for Health and Care Excellence  clinical criteria for OA;
age ≥ 45 years;
report activity-related knee joint pain and;
report no morning stiffness or morning knee stiffness lasting ≤30 mins;
report history of knee pain ≥3mths;
report knee pain on most days of the past month;
report an average pain score ≥ 4 on an 11-point numeric rating scale during walking over the previous week;
report difficulty walking and climbing stairs;
access to a device with internet connection;
willing and able to travel to the nearest trial physiotherapist if required; and
pass the Exercise and Sports Science Australia stage 1 pre-exercise screening questions .
Participants are excluded if they:
are unable to speak English;
are on a waiting list/planning for knee/hip surgery in next 12 months;
have had previous arthroplasty on affected knee;
report recent knee surgery (past 6 months);
are currently consulting/ed. a physiotherapist or doing strengthening exercise for their knee (past 6 months);
report any inflammatory arthritis (e.g. rheumatoid arthritis);
report any neurological condition affecting lower limbs; and/or
report any unstable/uncontrolled cardiovascular condition.
Anyone who i) reports a fall (past 12 months) or is house-bound due to immobility; or ii) who fails the Exercise and Sports Science Australia stage 1 pre-exercise screening questions is asked to obtain clearance from a general practitioner to participate. In cases where an eligible participant has bilateral knee symptoms, the most symptomatic knee is considered the study knee.
The flow of participants through the RCT is outlined in Fig. 1. All potential participants receive oral and written information about the purposes, potential risks and processes involved in the study from the Trial Coordinator. Once participants pass the telephone screening process, which involves a detailed verbal description of the project, they are sent a Plain Language Statement and Consent Form in the post or by email. Ethical approval has been obtained from the University of Melbourne Human Research Ethics Committee (HREC No. 1953585.1). All participants provide written informed consent.
All outcomes are participant-reported. Participants complete outcome assessments via electronic survey (REDCap) or paper-based (returned via mail for the minority that may request this). In addition, all participants record attendance at, and travel information about, physiotherapy consultations using a log book which is mailed back to research staff. As a reminder, research staff contact any participant who has failed to submit a survey and/or return a log book by the due date. Every effort is being made to minimize loss of data, including collection of primary outcome data over the telephone if necessary.
Immediately upon receipt of the signed consent form and completed baseline survey, a participant is randomized to either video-conferencing or face-to-face consultations with the trial physiotherapist of their choice (usually selected on the basis of geographical location). Participants are provided five physiotherapy consultations over a 12-week intervention period. Research staff book the first two consultations on behalf of the participant with the physiotherapist’s clinic at mutually agreeable times. Thereafter, the physiotherapist and participants arrange subsequent bookings together at the conclusion of each consultation.
Randomisation, blinding and allocation concealment
The randomisation schedule was prepared by a biostatistician using permuted block sizes 6 to 12 and a randomisation ratio of 1:1, stratified by trial physiotherapist. Where physiotherapists practice at two different clinic locations, randomisation is stratified by location within the physiotherapist. The randomisation schedule is stored on a password-protected website (REDCap) at the University of Melbourne and maintained by a researcher not involved in either participant recruitment or administration of primary/secondary outcome measures. Group allocation is revealed by this same researcher after baseline assessment has been completed.
Participants are blinded to group allocation by a process of limited disclosure. Participants are informed that physiotherapy services in the ‘real-world’ may be provided in a variety of settings and models of delivery, such as face-to-face care, telephone consultations, video-conferencing, individual consultations, group classes, community health services, rehabilitation services, private practices and hospital settings and home visits. They are informed that the purpose of the RCT is to compare the effectiveness of two different models of physiotherapy service. Although participants are informed they will receive a series of consultations with a physiotherapist (for education, strengthening exercise and a physical activity plan), they are not told that video-conferencing is being compared to face-face individual consultations. Participants will not be informed about the study hypotheses, or the model of care received by the comparator group, until the study is completed, at which time they will also be provided a lay summary of findings. As all outcomes are participant-reported, and participants are blinded, this study is thus also considered assessor-blinded. It is not possible to blind physiotherapists as they are providing consultations to both trial arms (in order to ensure physiotherapist-related factors such as personality, clinical practice experience etc. are similar across groups and cannot confound results). Statistical analyses will be performed in a blinded manner.
Fifteen practicing musculoskeletal physiotherapists in private practice in Victoria and Queensland were recruited via Australian Physiotherapy Association electronic communications channels, and our own clinical networks. These physiotherapists deliver care to participants randomized to both trial arms. Eligibility criteria for the physiotherapists to participate were:
Current registration to practice as a physiotherapist;
Have a receptionist at their clinical practice to facilitate patient bookings and communication with research staff;
Have access to a desktop or laptop computer with internet connection and suitable work-space for private video consultations in their clinical rooms;
Have an Australian Business Number;
Have some previous experience and confidence using video conferencing software (e.g. Skype, Zoom, FaceTime);
Willing to undertake trial training requirements; and
Be willing and available to participate in the RCT until end of 2021.
Mandatory training was undertaken by all physiotherapists prior to being allocated a trial participant. Training included:
Bespoke self-directed e-learning modules (delivered on the University of Melbourne Learning Management System) about best-practice OA management, telehealth (including delivery of care via Zoom video-conferencing) and trial procedures, including the structured physiotherapy treatment protocol. Physiotherapists were told it would take approximately 5 h to work through all e-learning modules, which they were encouraged to complete at their own pace, ideally over 4 weeks. The PEAK Training Program e-learning modules have since been adapted, and released, for widespread use by clinicians outside of the trial and access is available to users from all over the globe via https://healthsciences.unimelb.edu.au/departments/physiotherapy/about-us/chesm/news-and-events/peak-training-program/);
A mock initial consultation via video-conferencing with a researcher acting as a patient, who provided immediate feedback on performance;
Four video consultations, with two pilot patients with knee pain recruited by research staff (an initial and a follow-up call for each patient), to practice video consultation skills. Physiotherapists completed a self-reflection exercise upon completion of the pilot consultations (What went well? What didn’t go so well? What would I do differently in future?). Research staff conducted “spot” checks of consultation recordings and provided feedback to individual physiotherapists regarding performance after all pilot consultations were complete;
A video-conference with research staff to answer any questions about trial procedures.
A hard copy of the trial protocol and procedures relevant to the physiotherapist (incorporated into a single physiotherapist trial manual), as well as a copy of each participant resource (see below) was also provided to each physiotherapist.
Each trial participant is mailed a “welcome pack” of resources to facilitate the management plans that physiotherapists enact during the consultations. These resources include:
Four information booklets:
“Preparing for your consultations” (information about consultations, instructions on how to use Zoom video-conferencing and activity tracker);
“Osteoarthritis Information” (information about knee OA, common management options, exercise and physical activity, weight loss, pain management, sleep and success stories);
“Exercise Booklet” (strengthening exercise instructions and photos, including information on progressing exercises, managing flare-ups and dealing with set-backs); and
“Knee Plan and Log Book” (templates to record details of management plans agreed upon at each consultation and monitor progress with exercise and physical activity goals).
Four coloured elastic resistance bands (red, green, blue, and black) for home-based strengthening exercises; and
A wearable activity tracker to facilitate physical activity plans (Mi Band 4, Anhui Huami Information Technology Co. Ltd., China) or pedometer (Omron Healthcare, USA).
In both trial arms, five consultations are offered with the physiotherapist over 3 months (at approximately weeks 1, 2, 4, 7, 10), each lasting 30 min except the first which is 45 min. Participants are asked to complete an electronic pre-consultation survey prior to their first physiotherapy consultation, which ascertains information about their knee symptoms, previous treatments, activity levels and personal goals. This survey is forwarded to the physiotherapist prior to the first consultation.
Table 1 provides an overview of the main components of each physiotherapy consultation. Consultations have been informed by the Behaviour Change Wheel  (including behaviour change techniques relevant for exercise and physical activity [21, 22], Table 2) and based on the research team’s prior research into exercise and physical activity for knee OA [11, 23,24,25,26,27]. In summary, physiotherapists aim to prescribe an individualised exercise program comprising 5–6 strengthening exercises to be performed at home three times/week, including two quadriceps exercises, one hip/gluteal exercise, one hamstrings/gluteal exercise, one calf exercise, and one other as appropriate. Exercises are selected from an Exercise Booklet containing 37 exercises in total (Table 3), many with a range of potential variations to make them harder or easier as required. The intensity for the strengthening exercises is aimed at 5–7 out of ten (or, “hard to very hard”) on the modified Borg Rating of Perceived Exertion (RPE) scale  for strength training. Review and modification of the strengthening program occurs at each consultation. Progression is guided by American College of Sports Medicine principles  via adjustments to repetitions, direction, and speed of movements; increasing resistance; and/or changing stance surface.
Physiotherapists also work with the patient to devise an individualised physical activity plan, with the aim of increasing physical activity to, or maintaining it at, recommended levels . Participants use a wearable activity tracker to assist this and the physiotherapist and participant devise individualised step goals that are reviewed and modified (if required) at each consultation. Participants are encouraged to use the “Knee Plan and Log Book” for recording both their strengthening exercise program and physical activity plan after each consultation, and monitoring progress for discussion with the physiotherapist at the next consultation. Education about OA and its management occurs at all sessions, including discussion about the role of exercise and physical activity, including barriers to adherence and strategies for overcoming obstacles. Table 1 outlines the different education topics at each consultation.
Participants are encouraged and advised how to independently progress their exercise program and their physical activity plan between consultations, and beyond, once the physiotherapist consultations have ceased. Participants are encouraged to continue with their strengthening exercises and physical activity plan after the physiotherapist consultations have finished, up until the final outcome measurements are collected at 9 months. Participant use of monitoring and tracking tools (“Knee Plan and Log Book”; wearable activity tracker) is encouraged during the consultations, and beyond, to facilitate ongoing adherence to strengthening exercise and physical activity.
Mode of physiotherapy delivery
Face-to-face consultations – participants allocated to this group attend all of their consultations with the physiotherapist in the physiotherapist’s clinical practice rooms. Participants travel to and from the clinic at their own expense. Physiotherapists use their usual clinical methods for teaching the strengthening exercise program (ie demonstration, watching and correcting participant technique). Consultations are audio-recorded using digital audio recorders and uploaded by the physiotherapist to a secure password-protected cloud-based system.
Video consultations - participants allocated to this group attend all of their consultations using the video-conferencing facility of Zoom (Zoom Video Communications, Inc., USA), a commercial cloud-based system accessible from any internet-connected computer, laptop or mobile device. Physiotherapists consult from their clinic using a lap-top or desk-top computer, whilst participants are based at their home (or elsewhere if preferred). Instructions for accessing and downloading Zoom are provided to participants and participants are encouraged to independently set themselves up in readiness for their first consultation. Physiotherapists are given access to a bespoke website containing a video library of all exercises contained within the “Exercise Booklet” so that they can provide real-time demonstration of exercises to participants during video-conferencing, using the share-screen feature of Zoom. Participants do not have access to the online video library outside of the consultations. Video-conferencing consultations are video-recorded via Zoom and files are stored on a secure password-protected cloud-based system.
Bespoke semi-structured consultation notes (paper-based or electronic according to physiotherapist preference) will be recorded by the physiotherapist for each consultation and returned to research staff at the completion of the participant’s series of consultations. Notes will be scrutinised by research staff for physiotherapist adherence to trial protocols. Fidelity will be recorded as the number and proportion of i) strengthening exercise programs prescribed by the second consultation; ii) physical activity plans prescribed by the second consultation; iii) follow-up consultations that reviewed strengthening programs; iv) follow-up consultations that reviewed physical activity plans; v) consultations where the RPE for the strength program was between 5 and 7; vi) all consultations that included education. The mean (SD) RPE for each participant’s strengthening exercise program will be determined over their consultations, as recorded in the treatment notes.
There is no single common symptom that drives all people with knee OA to seek care from a physiotherapist. However, the two predominant reasons are for relief of knee pain and/or assistance with physical dysfunction [31, 32]. Furthermore, assessing both of these symptoms as quality indicators for the primary care of OA, is advocated [33, 34]. Thus we have chosen co-primary outcomes of change in i) pain; and ii) physical function, both of which are also specifically advocated for use in clinical trials in people with knee OA [35, 36]. The primary end-point is 3 months and the secondary end-point is 9 months. Change scores at each end-point are calculated using data measured at baseline, 3 months and 9 months using the following tools:
Severity of knee pain during walking
Average pain on walking in the last week is measured using an 11-point NRS with terminal descriptors ‘no pain’ (score = 0) and ‘worst pain possible’ (score = 10) from baseline, 3, and 9 months. This scale has demonstrated reliability in OA .
Physical function subscale of the Western Ontario and McMaster universities osteoarthritis index (WOMAC)
The Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index (Likert version 3.1) is used to assess limitations with physical functioning . The self-reported tool is a disease-specific instrument which has established validity, reliability and responsiveness in an extensive range of OA studies . The subscale contains 17 questions on knee function over the past week, with Likert response options from ‘no dysfunction’ (score = 0) to ‘extreme dysfunction’ (score = 4). Total score ranges from 0 to 68, with higher scores indicating worse function.
For quality of life, physical activity and self-efficacy, change scores are calculated using data measured at baseline, 3 months and 9 months. Other secondary outcomes are measured at time-points as indicated below:
Health-related quality of life
Health-related quality of life is evaluated using the Assessment of Quality of Life (AQoL) (version AQoL-6D) . The AQoL-6D contains 20 items that assess independent living, mental health, relationships, pain, coping and senses. Total scores range from − 0.04 to 1.00, with higher scores indicating better quality of life.
Physical activity levels
Physical activity over the previous week is assessed using self-report tool, the Physical Activity Scale for the Elderly (PASE) . Total PASE scores range from 0 to over 400, with higher scores indicating greater physical activity.
Using the 8-item Arthritis Self Efficacy Scale , participants rate how certain they are that they can do 8 tasks using response options ranging from 1 (very uncertain) to 10 (very certain). Total scores are an average of the 8 items with a range from 1 to 10; higher scores indicate higher self-efficacy.
Participant-perceived global change
Participants rate their overall global i) change in pain, ii) change in physical function, and iii) change in physical activity at 3- and 9-months using separate 7-point Likert scales with terminal descriptors of ‘much worse’ to ‘much better’ . For each scale, participants that indicate they are ‘moderately better’ or ‘much better’ are classified as ‘improved’ and all others as ‘not improved’.
Satisfaction with the physiotherapy consultations
Participants rate their satisfaction with the physiotherapy consultations at 3- and 9-months using a 7-point Likert scale with terminal descriptors of ‘extremely unsatisfied’ to ‘extremely satisfied’. Participants who report being ‘moderately satisfied’ or ‘extremely satisfied’ are classified as ‘satisfied’ and all others as ‘not satisfied’.
The Working Alliance Inventory Short Form  is scored separately by both the participant (at 3-months) and the physiotherapist (after the 5th consultation or on the day the 5th consultation was due to be scheduled for participants who cancel/do not attend). Overall scores range from 12 to 84, with higher scores indicating a stronger therapeutic alliance.
Participants rate the convenience of their physiotherapy consultations at 3 months using an 11-point NRS with terminal descriptors of ‘extremely inconvenient’ (score = 0) and ‘extremely convenient’ (score = 10).
Attendance at consultations
Attendance at each consultation is recorded by physiotherapists in treatment notes, and by participants in an “Appointment Log Book”. The number of consultations attended, number of consultations cancelled/rescheduled, and number of consultations that were a “failed to attend” are reported throughout the 3-month intervention period.
Adherence with strengthening exercise program
At the 3-month and 9-month follow-up assessments, participants rate their adherence with their prescribed strengthening exercise program (“I have been doing my exercises exactly as I was asked to by my PEAK trial physiotherapist (number of sessions, exercises and repetitions)”) using an 11-point NRS (with terminal descriptors of ‘strongly disagree’ (score = 0) and ‘strongly agree’ (score = 10)). At each time-point, participants also self-report the number of strengthening exercise sessions performed over the previous week.
Adherence with physical activity plan
At the 3-month and 9-month follow-up assessments, participants rate their adherence with their physical activity plan (“I followed the physical activity plan that my PEAK trial physiotherapist helped me to develop”) using an 11-point NRS (with terminal descriptors of ‘strongly disagree’ (score = 0) and ‘strongly agree’ (score = 10)).
Participants self-report any co-intervention use (medications for knee pain and any other treatments for knee OA) at baseline, 3, 6 and 9-months as part of the custom-developed survey collecting health service usage data (see below).
Participants who experience any adverse outcomes are instructed to discuss these with their physiotherapist, who institutes appropriate advice and/or changes to the strengthening exercise program and/or physical activity plan. Any risks to participants are likely to be minor and transient. In this trial, adverse events are defined as any problem experienced in the study knee or elsewhere in the body deemed by the participant to be a result of the exercises, physical activity plans and/or advice given by the physiotherapist AND at least one of i) that caused increased pain and/or interfered with function for 2 days or more, and/or ii) resulted in the participant seeking treatment from a health professional. Adverse events are ascertained by survey questions to participants at 3 and 9 months. The number and type of events are reported.
Health service usage
Participants retrospectively recall their health service usage for their knee pain and/or as a result of trial participation over 3-month intervals. Participants complete a custom survey to indicate the frequency of visits to health care providers for their knee pain, use of prescription and over the counter medication, injections, hospitalisation and investigative procedures at baseline, 3, 6 and 9 months.
Participants record their total time spent per consultation (including travelling to/from, waiting and consultation time) in an Appointment Log Book. Mean time for consultations is reported.
Physiotherapists record their total time spent per consultation (excluding note-taking and appointment scheduling). Mean time for consultations is reported.
Distance travelled to attend consultations, along with mode of transport (including vehicle descriptions and need for another person to accompany (if applicable)), is recorded by participants in an Appointment Log Book. Mean distance travelled, mode of transport and need for another person is reported.
A range of participant self-reported descriptive measures are recorded at baseline including recruitment source; data collection mode; height; body mass; body mass index; age; gender; duration of symptoms; geographical residential location; education level; current employment status; problems (pain, aching, discomfort or stiffness) in other joints; comorbidities (via the Self-Administered Comorbidity Questionnaire ); expectation of treatment outcome (rated on a 5-point ordinal scale with anchors of “no effect at all” to “complete recovery”); confidence using technology in day to day life; frequency of use of a range of technologies; beliefs about different models of physiotherapy care delivery and previous experience with different models of physiotherapy care delivery.
Sample size calculations
Sample size is based on detecting non-inferiority of video consultations relative to face-to-face at 3 months after randomisation. For change in NRS pain, a non-inferiority margin (NIM) of 0.95 units was chosen as this is less than the lowest of the range (1.0–2.0 units) [46, 47] reported as the minimum clinically important difference (MCID) by people with chronic pain, and less than the MCID of 1.75 units (extrapolated from a 100 mm visual analogue scale (VAS))  for OA by clinician consensus. For change in WOMAC subscales, a NIM of 8 mm on VAS versions of WOMAC (score 0–100) is used in drug non-inferiority RCTs , as it is less than the MCIDs of 9.1–9.3 mm [50, 51]. We are using the Likert version of WOMAC (scored 0–68) for function, thus our NIM for change in function is 5.44 units (extrapolated from 8 mm). Assuming standard deviations (SD) of changes from baseline of 2.8 and 15 units for pain and function respectively and correlations of 0.3 between baseline and follow-up [11, 26], 15% loss to follow-up, 90% power, and a one-sided 2.5% significance level, we need 197 people/arm for change in pain and 172/arm for change in function, a total of 394 people.
Statistical analysis plan
The a priori statistical analysis plan is described below. Any future amendments to this statistical plan will be documented, dated and explained in an electronic log kept by the research team, which will be made available upon request. A biostatistician will perform data analyses.
Consistent with OARSI guidelines , non-inferiority will be assessed using the per-protocol dataset (including only those randomized participants who attended ≥3 consultations). Between-group differences in mean change in pain and function (baseline minus follow-up) will be compared using linear regression modelling adjusted for baseline and the stratifying variable of physiotherapist. If a physiotherapist treats participants at two locations, two separate terms for that physiotherapist, corresponding to each location, will be included. Non-inferiority will be demonstrated if the lower bound of the two-sided 95% CI for between-group difference (video-conferencing minus face-to-face) is above − 0.95 for change in pain and/or − 5.44 for change in function, at 3 months. 95% CIs correspond to testing the null hypothesis of non-inferiority at a one-sided significance level of 2.5%. Due to difficulties with their interpretation, p-values associated with non-inferiority hypotheses are not commonly reported and will not be reported here . Multiple imputation will be used to impute missing data, and an intention-to-treat analysis (including all participants in their randomised groups) will be conducted to help assess robustness of conclusions (sensitivity analysis). Given that participants with knee OA seek physiotherapy care for different reasons, we will interpret and report findings transparently and separately for each co-primary outcome. For example, if we demonstrate non-inferiority of video consultations with respect to function but not pain, we will conclude that video consultations are non-inferior to face-to-face care for improving function but are inferior for pain relief in people with knee OA. Patients seeking care, and physiotherapists delivering care, will then be fully informed about benefits, and limitations, of video consultations compared to face-to-face care with respect to the different co-primary outcomes. If non-inferiority of a co-primary outcome is demonstrated, superiority of the outcome will then be assessed using the intention-to-treat dataset and declared if the lower bound of the two-sided 95% CI for between-group difference exceeds zero.
Secondary outcomes will be assessed using data from all participants (i.e. the intention-to-treat sample) and confidence intervals will be interpreted using the superiority framework since we have not pre-defined any NIMs for these outcomes. Linear regression models will be fit to compare continuous outcomes; proportional odds models to compare improvement based on global change; and Poisson or negative binomial regression models to compare count outcomes as appropriate. Assumptions will be assessed using standard diagnostic plots and methods. Since these are all secondary analyses, p-values for these assessments will not be adjusted for multiple comparisons [54, 55]. In addition, the outcomes of participant time, physiotherapist time and travel time will be compared between treatment groups using the superiority framework, similarly to other secondary outcomes.
Irrespective of the outcomes of the non-inferiority analysis, we will conduct exploratory analyses to evaluate moderation of the effect of video-conferencing versus face-to-face consultations on primary outcomes by pre-specified potential moderators, i) experience with online video platforms; ii) geographical residence; iii) beliefs about physiotherapy care delivery; and iv) confidence using technology. This will be assessed by including appropriate interaction terms between the moderators and the intervention term, where the superiority framework will be applied for interpreting results. The a priori hypotheses to be tested are:
Participants who are less frequent users of video platforms will have less improvement in primary outcomes with video consultations (relative to face-to-face), compared to participants who are more frequent users.
Participants who don’t live in major city areas will report greater ease of access, and reduced participant-level time and financial costs (secondary outcomes) with video consultations (relative to face-to-face), compared to participants who live in major cities.
Participants who believe that video consultations are less effective for managing musculoskeletal problems will report less improvement in primary outcomes with video consultations (relative to face-to-face), compared to those who believe video consultations are more effective.
Participants who are less confident with using technology will report less improvement in primary outcomes with video consultations (relative to face-to-face), compared to participants who are more confident.
A health economist will oversee assessment of incremental direct and indirect costs of video consultations compared to face-to-face. Primary evaluation will be between-group difference in knee-related health care costs and quality-adjusted life years (QALYs) using generalised linear models to adjust for baseline. Non-inferiority in QALYs will be demonstrated if the lower bound of the two-sided 95% CI for between-group difference of the AQoL-6D is above − 0.08 (half a SD). If one type of consultation is superior but costs more, QALYs will be calculated using area under the curve over 9 months. The incremental cost per QALY as the ratio of difference in mean cost to difference in mean QALYs, and net benefits as the difference in QALYs times the social value of a QALY minus the difference in cost, will then be calculated. If non-inferiority of QALYs is demonstrated, then inferiority in terms of cost (and net benefits) will then be assessed if the lower bound of the two-sided 95% CI for between-group difference exceeds zero. In a secondary analysis, the cost of patient time will be included as an additional cost component.
Patient and public involvement
No patients were involved in setting the research question. Patients with knee OA were involved in i) review of the plain language statement and consent form, particularly the text related to limited disclosure; ii) review and completion of the electronic outcome measurement survey; iii) testing the participant instructions for, and use of, the wearable activity tracker; iv) testing participant instructions for, and use of, Zoom for video-conferencing; v) review of other participant resources (Osteoarthritis Information, Exercise Booklet) and the Appointment Log Book used in data collection; vi) creation of telehealth training videos for the physiotherapist e-learning modules, and exercise videos/photographs for the website/Exercise Booklet, as patient actors; and vii) review of study logo. Patients provided feedback to the research team about information content, presentation and readability, as well as time taken to complete the outcome measurement survey. Patients with knee OA also participated in pilot “practice consultations” with the trial physiotherapists as part of the physiotherapist’s training procedures.
Representatives of the national physiotherapy professional body (Australian Physiotherapy Association) were involved in designing the trial (including selecting outcome measures) and obtaining funding. The Australian Physiotherapy Association assisted in physiotherapist recruitment by advertising for physiotherapists to participate in the trial via member electronic communications. Physiotherapists (not otherwise involved in the trial) i) reviewed the exercises contained within the “Exercise Booklet” and suggested the addition of three new balance exercises; ii) reviewed and provided feedback on the physiotherapist “Zoom Troubleshooting” resource embedded within the e-learning modules and physiotherapist trial manual; and iii) performed as actors/models in the creation of telehealth training videos for the physiotherapist e-learning modules.
The trial protocol underwent independent review by the ANZMUSC Clinical Trials Network, which included a written submission and a verbal presentation in an open forum to ANZMUSC members, review by two members from each of the Scientific Advisory Committee and the Consumer Advisory Group. The trial was endorsed by ANZMUSC on 25/07/2019, indicating its high priority and quality, importance to consumers/patients, clinicians and policy makers, and its potential to improve patient outcomes.
Ethics approval was obtained from the University of Melbourne Human Research Ethics Committee in May 2019. Physiotherapists were recruited and underwent training (on a rolling basis) between October 2019 and March 2020. Participant recruitment commenced in November 2019 and is anticipated to be completed in August 2021 but may be extended depending on the impact of the COVID-19 pandemic on recruitment rates. The trial is currently anticipated to be completed by May 2022, when all participants are currently anticipated to have completed 9-month follow-up.
Although our prior research  showed that video consultations with a physiotherapist (combined with pain coping skills training) are efficacious compared to online education, it remains unclear how effective video consultations are compared to traditional face-face physiotherapy care. Physiotherapy is viewed by the public and the wider healthcare community as a profession associated with “hands-on” and “physical” treatments. Foster and Delitto  have described how perceptions of physiotherapy professional culture form, and how patient preferences and expectations drive clinician practice and beliefs. Patients often expect to receive manual therapy treatments when consulting a physiotherapist, and physiotherapists themselves have traditionally been trained in a biomedical approach emphasising “hands-on” assessment and treatment techniques, despite the limited evidence for these approaches in many chronic musculoskeletal conditions, including knee OA. Robust high-quality non-inferiority RCTs are required to provide evidence that video consultations are non-inferior to face-to-face care in order to drive changes in service delivery models and funding policy.
Our trial is robust and will provide high-quality evidence about the effectiveness of video-conferencing compared to face-to-face physiotherapy care. Most pragmatic RCTs are superiority trials, which assess if a new approach is more effective than another standard intervention. In contrast, non-inferiority trials assess whether the effects of the new approach are within a predefined clinically acceptable margin of the effects of the standard approach . Non-inferiority RCTs typically require larger sample sizes than superiority trials because the NIM is typically smaller than the treatment effect that a similar superiority trial comparing the standard treatment to a comparison/placebo would be powered to detect. The study power of non-inferiority trials is usually chosen to be high (usually 90%) to minimise the risk that a non-inferior treatment is missed due to chance . Within our RCT, we plan to conduct a linked discrete choice experiment exploring patient preferences for receiving physiotherapy care, as well as qualitative evaluations of i) physiotherapist experiences with training for the trial; and ii) physiotherapist and patient experiences with, and attitudes towards, video consultations. These linked studies will be reported separately from the main trial findings.
A systematic review and meta-analysis evaluated the effectiveness of treatment delivered via telerehabilitation for musculoskeletal conditions . Of the 14 trials included, only three in people with OA were identified (one of these with a sample of mixed arthritic diagnoses) and none investigated video consultations. All three were superiority trials that utilized the telephone for consultations, and only one evaluated physiotherapy. Although a large equivalence trial showed that telephone-delivered physiotherapy care was equally clinically effective as usual care in the UK , a diverse sample of participants with mixed musculoskeletal conditions was recruited and video consultations were not evaluated. The paucity of literature evaluating the effectiveness of video consultations for management of knee OA is a barrier to its implementation as an alternative method of delivering care by physiotherapists. A significant limitation is the absence of data about its cost-effectiveness.
The Australian Telehealth Society has called for increased research to better understand the economic benefits of telehealth, particularly for patients and the broader health system, and not just funders of services . In its National Telehealth Strategy, the Australian Telehealth Society has also recognized the need to investigate the impact of telehealth on consumers, arguing telehealth will not succeed unless consumers can access it and find value in it . Key actions in this Strategy include determining consumer attitudes, enablers and barriers to telehealth and assessment of consumer feedback from telehealth trials. Findings from the PEAK RCT will provide valuable evidence about the clinical effectiveness and cost-effectiveness of video-conferencing by physiotherapists for people with knee OA. Results will inform the development and implementation of telehealth physiotherapy models and will have relevance to other chronic musculoskeletal diseases where education, exercise and physical activity are a cornerstone of management. Trial findings will be particularly relevant in light of the COVID-19 pandemic which has prompted many health services globally to switch from face-to-face consultations to video-conferencing in order to protect the health of both patients and staff.
Availability of data and materials
The datasets used and/or analysed during the current study will be made available from the corresponding author on reasonable request.
Australia & New Zealand Musculoskeletal Clinical Trial Network
Assessment of Quality of Life
Consolidated Standards of Reporting Trials
Human Research Ethics Committee
Minimally clinically important difference
Numerical rating scale
Osteoarthritis Research Society International
Physical Activity Scale for the Elderly
Plain Language Statement
Randomised controlled trial
Standard Protocol Items: Recommendations for Intervention Trials
Visual analogue scale
Western Ontario and McMaster Universities
Arthritis and Osteoporosis Victoria: A Problem Worth Solving. The rising cost of musculoskeletal conditions in Australia; 2013.
Global Burden of Disease 2017 Disease and Injury Incidence and Prevalence Collaborators: Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1789–858.
Safiri S, Kolahi AA, Smith E, Hill C, Bettampadi D, Mansournia MA, Hoy D, Ashrafi-Asgarabad A, Sepidarkish M, Almasi-Hashiani A, et al. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the global burden of disease study 2017. Ann Rheum Dis. 2020;79(6):819–28.
Fernandes L, Hagen KB, Bijlsma JW, Andreassen O, Christensen P, Conaghan PG, Doherty M, Geenen R, Hammond A, Kjeken I, et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis. 2013;72(7):1125–35.
Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA, Kraus VB, Lohmander LS, Abbott JH, Bhandari M, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil. 2019;27(11):1578–89.
National Clinical Guideline Centre: Osteoarthritis. Care and management in adults. Clinical guideline CG177. Methods, evidence and recommendations: London, National Institute for Health and Care Excellence (UK); 2014.
The Royal Australian College of General Practitioners. Guideline for the management of knee and hip osteoarthritis. 2nd ed. East Melbourne: RACGP; 2018.
Fransen M, McConnell S, Harmer AR, van der Esch M, Simic M, Bennell KL. Exercise for osteoarthritis of the knee. Cochrane Database Syst Rev. 2015;1:CD004376.
Uthman OA, van der Windt DA, Jordan JL, Dziedzic KS, Healey EL, Peat GM, Foster NE. Exercise for lower limb osteoarthritis: systematic review incorporating trial sequential analysis and network meta-analysis. Bmj. 2013;347:f5555.
Hinman RS, Hunt M, Simic M, Bennell KL. Exercise, gait retraining, footwear and insoles for knee osteoarthritis. Curr Phys Med Rehabil Rep. 2013;1:21–8.
Bennell KL, Nelligan R, Dobson F, Rini C, Keefe F, Kasza J, French S, Bryant C, Dalwood A, Abbott JH, et al. Effectiveness of an internet-delivered exercise and pain-coping skills training intervention for persons with chronic knee pain: a randomized trial. Ann Intern Med. 2017;166(7):453–62.
Hinman RS, Nelligan RK, Bennell KL, Delany C. "sounds a bit crazy, but it was alsmost more personal:" a qualtitative study of patient and clinician experiences of physical therapist-prescribed exercise for knee osteoarthritis via skype. Arthritis Care Res. 2017;69:1834–44.
Lawford BJ, Bennell KL, Hinman RS. Consumer perceptions of and willingness to use remotely delivered service models for exercise management of knee and hip osteoarthritis: a cross-sectional survey. Arthritis Care Res. 2016;69(5):667–76.
Cottrell MA, Hill AJ, O'Leary SP, Raymer ME, Russell TG. Patients are willing to use telehealth for the multidisciplinary management of chronic musculoskeletal conditions: a cross sectional survey. J Telemed Telecare. 2018;24(7):445–52.
Russell TG, Buttrum P, Wootton R, Jull GA. Internet-based outpatient telerehabilitation for patients following total knee arthroplasty: a randomized controlled trial. J Bone Joint Surg (Am Vol). 2011;93(2):113–20.
Chan A, Tetzlaff JM, Altman DG, et al. Spirit 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–7.
Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG, Group C. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012;308(24):2594–604.
Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P, Group CN. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40–7.
Exercise and Sports Science Australia: Adult Pre-exercise Screening System; 2012.
Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42.
Michie S, Ashford S, Sniehotta FF, Dombrowski SU, Bishop A, French DP. A refined taxonomy of behaviour change techniques to help people change their physical activity and healthy eating behaviours: the CALO-RE taxonomy. Psychol Health. 2011;26(11):1479–98.
Nicolson PJA, Hinman RS, French SD, Lonsdale C, Bennell KL. Improving adherence to exercise: do people with knee osteoarthritis and physical therapists agree on the behavioral approaches likely to succeed? Arthritis Care Res. 2018;70(3):388–97.
Bennell KL, Hunt MA, Wrigley TV, Hunter DJ, McManus FJ, Hodges PW, Li L, Hinman RS. Hip strengthening reduces symptoms but not knee load in people with medial knee osteoarthritis and varus malalignment: a randomised controlled trial. Osteoarthr Cartil. 2010;18(5):621–8.
Bennell KL, Kyriakides M, Metcalf B, Egerton T, Wrigley TV, Hodges PW, Hunt MA, Roos EM, Forbes A, Ageberg E, et al. Neuromuscular versus quadriceps strengthening exercise in patients with medial knee osteoarthritis and varus malalignment: a randomized controlled trial. Arthritis Rheum. 2014;66(4):950–9.
Lim BW, Hinman RS, Wrigley TV, Sharma L, Bennell KL. Does knee malalignment mediate the effects of quadriceps strengthening on knee adduction moment, pain, and function in medial knee osteoarthritis? A randomized controlled trial. Arthritis Rheum. 2008;59(7):943–51.
Bennell KL, Campbell PK, Egerton T, Metcalf B, Kasza J, Forbes A, Bills C, Gale J, Harris A, Kolt GS, et al. Telephone coaching to enhance a home-based physical activity program for knee osteoarthritis: a randomised clinical trial. Arthritis Care Res. 2017;69(1):84–94.
Hinman RS, Campbell PK, Lawford BJ, Briggs AM, Gale J, Bills C, Kasza J, Harris A, French SD, Bunker SJ, et al. Does telephone-delivered exercise advice and support by physiotherapists improve pain and/or function in people with knee osteoarthritis? Telecare randomised controlled trial. Br J Sports Med. 2019;bjsports(2019):101183. https://doi.org/10.1136/bjsports-2019-101183.
Borg G, Ljunggren G, Ceci R. The increase of perceived exertion, aches and pain in the legs, heart rate and blood lactate during exercise on a bicycle ergometer. Eur J Appl Physiol Occup Physiol. 1985;54(4):343–9.
Pescatello LS. ACSM’s guidelines for exercise testing and prescription. Ninth edition. edn: Wolters Kluwer/Lippincott Williams & Wilkins Health; 2014.
Australian Government, Department of Health. Australia's Physical Activity and Sedentary Behaviour Guidelines and the Australian 24-Hour Movement Guidelines. 2019. https://www1.health.gov.au/internet/main/publishing.nsf/Content/health-pubhlth-strateg-phys-act-guidelines#npa1864. Accessed April 2020.
Prasanna SS, Korner-Bitensky N, Ahmed S. Why do people delay accessing health care for knee osteoarthritis? Exploring beliefs of health professionals and lay people. Physiother Can. 2013;65(1):56–63.
Thorstensson CA, Gooberman-Hill R, Adamson J, Williams S, Dieppe P. Help-seeking behaviour among people living with chronic hip or knee pain in the community. BMC Musculoskelet Disord. 2009;10:153.
Edwards JJ, Khanna M, Jordan KP, Jordan JL, Bedson J, Dziedzic KS. Quality indicators for the primary care of osteoarthritis: a systematic review. Ann Rheum Dis. 2015;74(3):490–8.
Edwards JJ, Jordan KP, Peat G, Bedson J, Croft PR, Hay EM, Dziedzic KS. Quality of care for OA: the effect of a point-of-care consultation recording template. Rheumatol. 2015;54(5):844–53.
Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, Altman R, Brandt K, Dougados M, Lequesne M. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol. 1997;24(4):799–802.
McAlindon TE, Driban JB, Henrotin Y, Hunter DJ, Jiang GL, Skou ST, Wang S, Schnitzer T. OARSI clinical trials recommendations: design, conduct, and reporting of clinical trials for knee osteoarthritis. Osteoarthr Cartil. 2015;23(5):747–60.
Bellamy N. Osteoarthritis clinical trials: candidate variables and clinimetric properties. J Rheumatol. 1997;24(4):768–78.
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–40.
McConnell S, Kolopack P, Davis AM. The Western Ontario and McMaster universities osteoarthritis index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum. 2001;45(5):453–61.
Osborne RH, Hawthorne G, Lew EA, Gray LC. Quality of life assessment in the community-dwelling elderly: validation of the assessment of quality of life (AQoL) instrument and comparison with the SF-36. J Clin Epidemiol. 2003;56(2):138–47.
Martin K, Rejeski W, Miller M, James M, Ettinger W Jr, Messier S. Validation of the PASE in older adults with knee pain and physical disability. Med Sci Sports Exerc. 1999;31(5):627–33.
Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum. 1989;32(1):37–44.
ten Klooster PM, Drossaers-Bakker KW, Taal E, van de Laar MA. Patient-perceived satisfactory improvement (PPSI): interpreting meaningful change in pain from the patient's perspective. Pain. 2006;121(1–2):151–7.
Horvath AO, Greenberg LS. Development and validation of the working Alliance inventory. J Couns Psychol. 1989;36(2):223–33.
Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156–63.
Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8(4):283–91.
Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149–58.
Bellamy N, Carette S, Ford P, Kean W, le Riche N, Lussier A, Wells G, Campbell J. Osteoarthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials. J Rheumatol. 1992;19(3):1992.
Zhang H, Zhang K, Zhang X, Zhu Z, Yan S, Sun T, Guo A, Jones J, Steen RG, Shan B, et al. Comparison of two hyaluronic acid formulations for safety and efficacy (CHASE) study in knee osteoarthritis: a multicenter, randomized, double-blind, 26-week non-inferiority trial comparing Durolane to Artz. Arthritis Res Ther. 2015;17:51.
Ehrich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N. Minimal perceptible clinical improvement with the Western Ontario and McMaster universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol. 2000;27(11):2635–41.
Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D, et al. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis. 2005;64(1):29–33.
Losina E, Ranstam J, Collins JE, Schnitzer TJ, Katz JN. OARSI clinical trials recommendations: key analytic considerations in design, analysis, and reporting of randomized controlled trials in osteoarthritis. Osteoarthr Cartil. 2015;23(5):677–85.
Wiens BL. Multiple comparisons in non-inferiority trials: reaction to recent regulatory guidance on multiple endpoints in clinical trials. J Biopharm Stat. 2018;28(1):52–62.
Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998;316(7139):1236–8.
Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43–6.
Foster NE, Delitto A. Embedding psychosocial perspectives within clinical management of low back pain: integration of psychosocially informed management principles into physical therapist practice--challenges and opportunities. Phys Ther. 2011;91(5):790–803.
Scott I. Non-inferiority RCTs. MJA. 2009;190:326–30.
Cottrell MA, Galea OA, O'Leary SP, Hill AJ, Russell TG. Real-time telerehabilitation for the treatment of musculoskeletal conditions is effective and comparable to standard practice: a systematic review and meta-analysis. Clin Rehabil. 2017;31(5):625–38. https://doi.org/10.1177/0269215516645148.
Salisbury C, Montgomery AA, Hollinghurst S, Hopper C, Bishop A, Franchini A, Kaur S, Coast J, Hall J, Grove S, et al. Effectiveness of PhysioDirect telephone assessment and advice services for patients with musculoskeletal problems: pragmatic randomised controlled trial. BMJ. 2013;346:f43.
Australasian Telehealth Society: National Digital Health Strategy; 2017.
Australasian Telehealth Society: Towards a National Strategy for telehealth in Australia 2013–2018; 2013.
The trial has been endorsed by the ANZMUSC Clinical Trial Network, indicating its high priority and quality, importance to consumers/patients, clinicians and policy makers, and its potential to improve patient outcomes.
This trial was prospectively registered by the Australian New Zealand Clinical Trials Registry on 9/9/2019 (reference: ACTRN12619001240134).
This study is funded by the National Health and Medical Research Council (Project Grant #1157977). RSH is supported by a National Health & Medical Research Council Senior Research Fellowship (#1154217). KLB is supported by a National Health & Medical Research Council Investigator Grant (#1174431). NEF is a National Institute for Health Research (NIHR) Senior Investigator. The funders have no role in conduct, analysis or reporting of this study.
Ethics approval and consent to participate
Ethical approval has been obtained from the University of Melbourne Human Research Ethics Committee (HREC No. 1953585.1). All participants are required to provide consent to participate. Participants are encouraged to phone researchers if they have any questions or concerns regarding the contents of the PLS and/or Consent Form. Consent is obtained online using REDCap prior to completion of the baseline questionnaire or participants sign a paper-based consent form and return it via a reply-paid envelope in the post or by scanning and emailing the document to research staff.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hinman, R.S., Kimp, A.J., Campbell, P.K. et al. Technology versus tradition: a non-inferiority trial comparing video to face-to-face consultations with a physiotherapist for people with knee osteoarthritis. Protocol for the PEAK randomised controlled trial. BMC Musculoskelet Disord 21, 522 (2020). https://doi.org/10.1186/s12891-020-03523-8
- Clinical trial
- Physical activity